Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 von Hippel-Lindau disease: treatment of retinal haemangioblastomas by targeted therapy with systemic bevacizumab.

× No keyword cloud information.

5 in total

1. Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial.

Authors: Eric Jonasch; Ian E McCutcheon; Dan S Gombos; Kamran Ahrar; Nancy D Perrier; Diane Liu; Christine C Robichaux; Mercedes F Villarreal; Justin A Weldon; Ashley H Woodson; Patrick G Pilie; Gregory N Fuller; Steven G Waguespack; Surena F Matin
Journal: Lancet Oncol Date: 2018-09-17 Impact factor: 41.316

Review 2. Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies.

Authors: R M Ruggeri; E Benevento; F De Cicco; B Fazzalari; E Guadagno; I Hasballa; M G Tarsitano; A M Isidori; A Colao; A Faggiano
Journal: J Endocrinol Invest Date: 2022-08-30 Impact factor: 5.467

von Hippel-Lindau disease: treatment of retinal haemangioblastomas by targeted therapy with systemic bevacizumab.

1. Pazopanib in patients with von Hippel-Lindau disease: a single-arm, single-centre, phase 2 trial.

Review 2. Neuroendocrine neoplasms in the context of inherited tumor syndromes: a reappraisal focused on targeted therapies.

3. Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease.

Review 4. Von Hippel-Lindau Disease: Current Challenges and Future Prospects.

5. 3-D OCT angiographic evidence of Anti-VEGF therapeutic effects on retinal capillary hemangioma.